IIT2021-07-Atkins-CARMA: Cardiac Aggressive Risk Mitigation in Thoracic Radiotherapy (CARMA) Trial
Status: Completed
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The purpose of this study is to examine adherence to cardio-oncology consultation.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Any stage (I-IV) malignancy being treated with high dose (≥30 Gy) radiotherapy where the heart is in the treatment field.
• Have Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0-2.
• Planning to receive standard of care radiotherapy treatments.
• Access to a smart device that has the capability to sync to the devices.
• Written informed consent obtained from subject and ability for subject to comply with the requirements of the study.
• Ability to read, write and understand English.
Locations
United States
California
Cancer Clinical Trials Office
Los Angeles
Time Frame
Start Date: 2022-10-07
Completion Date: 2023-06-16
Participants
Target number of participants: 20
Treatments
Experimental: CARMA
Cardiac Aggressive Risk MitigAtion plan with biosensor monitoring
Authors
Elizabeth McKenzie, David Ouyang, Amin Mirhadi, Katelyn Atkins, Stephen Shiao, Behrooz Hakimian, Mitchell Kamrava, Andriana Nikolova
Sponsors
Leads: Cedars-Sinai Medical Center